SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

12 Aug 2025 Evaluate
The sales for the June 2025 quarter moved down -39.21% to Rs. 628.60 millions as compared to Rs. 1034.10 millions during the year ago period.The Total Profit for the quarter ended June 2025 of Rs. 26.70 millions grew from Rs.-34.70 millionsOperating profit surged to 408.50 millions from the corresponding previous quarter of 264.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 628.60 1034.10 -39.21 628.60 1034.10 -39.21 3998.40 3273.50 22.14
Other Income 374.20 115.90 222.86 374.20 115.90 222.86 329.80 630.50 -47.69
PBIDT 408.50 264.90 54.21 408.50 264.90 54.21 1047.70 698.50 49.99
Interest 202.60 157.30 28.80 202.60 157.30 28.80 704.00 681.90 3.24
PBDT 205.90 107.60 91.36 205.90 107.60 91.36 343.70 -13.90 -2572.66
Depreciation 164.70 163.20 0.92 164.70 163.20 0.92 652.00 1016.10 -35.83
PBT 41.20 -55.60 -174.10 41.20 -55.60 -174.10 -308.30 -1030.00 -70.07
TAX 14.50 -20.90 -169.38 14.50 -20.90 -169.38 -209.60 -265.90 -21.17
Deferred Tax 14.50 -20.90 -169.38 14.50 -20.90 -169.38 -209.60 -376.50 -44.33
PAT 26.70 -34.70 -176.95 26.70 -34.70 -176.95 -98.70 -764.10 -87.08
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 31360.00 -99.00
PBIDTM(%) 64.99 25.62 153.69 64.99 25.62 153.69 26.20 21.34 22.80

Dishman Carbogen Amc Share Price

172.00 4.45 (2.66%)
21-Apr-2026 10:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.90
Dr. Reddys Lab 1222.90
Cipla 1231.00
Zydus Lifesciences 932.25
Lupin 2327.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×